EDIT
Price
$10.14
Change
-$0.39 (-3.70%)
Updated
Mar 4, 3:09 PM EST
58 days until earnings call
SANA
Price
$9.46
Change
-$1.81 (-16.06%)
Updated
Mar 4, 6:59 PM EST
64 days until earnings call
Ad is loading...

Compare trend and price EDIT vs SANA

Header iconEDIT vs SANA Comparison
Open Charts EDIT vs SANABanner chart's image
Editas Medicine
Price$10.14
Change-$0.39 (-3.70%)
Volume$2.01K
CapitalizationN/A
Sana Biotechnology
Price$9.46
Change-$1.81 (-16.06%)
Volume$3.14M
CapitalizationN/A
View a ticker or compare two or three
EDIT vs SANA Comparison Chart

Loading...

EDITDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SANADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
EDIT vs. SANA commentary
Mar 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a StrongBuy and SANA is a Hold.

COMPARISON
Comparison
Mar 04, 2024
Stock price -- (EDIT: $10.53 vs. SANA: $11.27)
Brand notoriety: EDIT and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 157% vs. SANA: 131%
Market capitalization -- EDIT: $860.02M vs. SANA: $2.47B
EDIT [@Biotechnology] is valued at $860.02M. SANA’s [@Biotechnology] market capitalization is $2.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than SANA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 5 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • EDIT’s TA Score: 5 bullish, 6 bearish.
  • SANA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SANA is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +34.83% price change this week, while SANA (@Biotechnology) price change was +36.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.56%. For the same industry, the average monthly price growth was +19.55%, and the average quarterly price growth was +53.65%.

Reported Earning Dates

EDIT is expected to report earnings on May 01, 2024.

SANA is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for EDIT with price predictions.
OPEN
A.I.dvisor published
a Summary for SANA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SANA($2.47B) has a higher market cap than EDIT($860M). SANA YTD gains are higher at: 176.226 vs. EDIT (3.949). EDIT has higher annual earnings (EBITDA): -163.12M vs. SANA (-266.82M). EDIT has more cash in the bank: 323M vs. SANA (269M). EDIT has less debt than SANA: EDIT (36.5M) vs SANA (96.9M). EDIT has higher revenues than SANA: EDIT (78.1M) vs SANA (0).
EDITSANAEDIT / SANA
Capitalization860M2.47B35%
EBITDA-163.12M-266.82M61%
Gain YTD3.949176.2262%
P/E RatioN/AN/A-
Revenue78.1M0-
Total Cash323M269M120%
Total Debt36.5M96.9M38%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITSANA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Ad is loading...
EDITDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SANADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETHSX14.030.18
+1.30%
Eaton Vance Worldwide Health Sci A
LICAX14.720.18
+1.24%
Lord Abbett International Equity A
CHTRX18.380.12
+0.66%
Invesco Charter A
IFACX23.330.15
+0.65%
American Funds Income Fund of Amer C
VESMX18.070.10
+0.56%
VELA Small Cap I

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with CRSP. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
+12.25%
CRSP - SANA
60%
Loosely correlated
-0.56%
NTLA - SANA
55%
Loosely correlated
+1.68%
BEAM - SANA
52%
Loosely correlated
+0.89%
EDIT - SANA
50%
Loosely correlated
+4.67%
NRIX - SANA
47%
Loosely correlated
+9.80%
More